Results 1 to 10 of about 665,793 (164)

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. [PDF]

, 2011
Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination is widely recommended for this group. This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in terms of ...
Kerac, Marko, Zanuzdana, A, Augustine, G, Kim, Sophie, Mukaigawara, M, Denness, H, Harris, Rebecca C., Parish, V, Stevenson, Charlotte, Wigglesworth, N, Haroon, M, Paul Fisher, Javier Peñalver, Beck, Charles R., Gemma Morgan, Charlotte Stevenson, Butt, Mobasher, Puleston, Richard, Vivienne Parish, Haroon, S, Rebecca C Harris, Hiroshi Horiuchi, Ahyow, L, Bruce C McKenzie, Jose Figureroa, Joanne Enstone, Marko Kerac, Puleston, R, Dabke, G, Figureroa, Jose, Hashim, Ahmed B., Nguyen-Van-Tam, JS, Ishola, David A, Peñalver, Javier, Figureroa, J, Mobasher Butt, Mary O'Brien, Hird, C, Laura Béchard-Evans, Harris, Rebecca, Wigglesworth, Neil, Glenda Augustine, Richard Puleston, Ishola, DA, Isba, Rachel, Felix Greaves, Peñalver, J, Sophie Kim, McKenzie, Bruce C., Béchard-Evans, L, Agboado, Gabriel, Weston, Rachel, Orton, Elizabeth, Liz Lingard, Caroline Hird, Stevenson, C, Augustine, Glenda, O'Boyle, J, Hashim, Ahmed B, Dabke, Girija, Rachel Isba, Morgan, Gemma, Theaker, S, Ishola, David A., Kerac, M, O'Brien, Mary, Mitsuru Mukaigawara, Elizabeth Orton, Beck, Charles, Theaker, Sarah, Rosser, Julia, Vinogradova, Yana, Siobhan Farmer, Dean Wallace, Horiuchi, Hiroshi, Weston, R, Vinogradova, Y, Béchard-Evans, Laura, Sophie Haroon, Wallace, D, O'Boyle, Julie, Nguyen-Van-Tam, Jonathan S, Neil Wigglesworth, Haroon, Sophie, Hashim, Ahmed, Helene Denness, Wallace, Dean, Lingard, L, Zanuzdana, Arina, Munib Haroon, McKenzie, Bruce C, Nguyen-Van-Tam, Jonathan, Agboado, G, Horiuchi, H, David A Ishola, Harris, Rebecca C, Gabriel Agboado, Rachel Weston, Yana Vinogradova, Nguyen-Van-Tam, Jonathan S., Robert Howard, Beck, CR, Orton, E, Kim, S, Lauren Ahyow, Jonathan S Nguyen-Van-Tam, Roberts, Jonathan, Fisher, P, Farmer, S, Jonathan Roberts, Ishola, David, Lingard, Liz, Enstone, Joanne, Howard, Robert, Greaves, Felix, Howard, R, Denness, Helene, Isba, R, Fisher, Paul, Enstone, J, Hird, Caroline, Julie O'Boyle, Harris, RC, Haroon, Munib, Mukaigawara, Mitsuru, Rosser, J, Girija Dabke, Arina Zanuzdana, Sarah Theaker, Butt, M, Greaves, F, McKenzie, BC, Ahyow, Lauren, Hashim, AB, Morgan, G, Farmer, Siobhan, Ahmed B Hashim, Charles R Beck, Beck, Charles R, Parish, Vivienne, Julia Rosser, McKenzie, Bruce, O'Brien, M, Roberts, J, Zanuzdana Arina, Morgan Gemma, Lingard Liz, Kerac Marko, Denness Helene, Kim Sophie, Orton Elizabeth, Agboado Gabriel, McKenzie Bruce C., Enstone Joanne, Parish Vivienne, Dabke Girija, Greaves Felix, Vinogradova Yana, Béchard-Evans Laura, Mukaigawara Mitsuru, Augustine Glenda, Roberts Jonathan, Weston Rachel, Haroon Munib, Hashim Ahmed B., Howard Robert, Isba Rachel, O'Boyle, J, O'Brien Mary, Theaker Sarah, Peñalver Javier, Beck Charles R., Wallace Dean, Rosser Julia, O'Boyle Julie, Ahyow Lauren, Puleston Richard, Stevenson Charlotte, Haroon Sophie, Ishola David A., Harris Rebecca C., Horiuchi Hiroshi, Fisher Paul, O'Brien, M, Figureroa Jose, Hird Caroline, Butt Mobasher, Nguyen-Van-Tam Jonathan S., Wigglesworth Neil, Farmer Siobhan   +189 more
core   +6 more sources

Serious Infection in Crohn's Disease Patients Treated With Ustekinumab: US Food and Drug Administration Active Postmarket Risk Identification and Analysis in the Sentinel Initiative. [PDF]

Clin Pharmacol Ther
The U.S. Food and Drug Administration (FDA) used an Active Postmarket Risk Identification and Analysis (ARIA) system to address a safety issue (serious infection) identified during clinical review of an application to market ustekinumab as a treatment for Crohn's disease (CD). FDA used an active‐comparator new‐user cohort design, data from six Sentinel
Weissfeld JL, Iyer GS, Seo SC, Giffin A, Simon AL, Kluberg SA, Hoffman ER, Jones JT, Dutcher SK, Korvick JA.   +9 more
europepmc   +2 more sources

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence [PDF]

, 2012
Foremost amongst the diseases preventable by vaccination is influenza. Worldwide, influenza virus infection is associated with serious adverse events leading to hospitalization, debilitating complications, and death in elderly individuals ...
Assir N, Lang, Pierre-Olivier, Govind, Sheila, Aspinall R, Mendes A, Mendes, Aline, Socquet, Jennifer, Govind S, Socquet J, Assir, Noémie, Lang PO, Aspinall, Richard   +11 more
core   +1 more source

Vacinação Contra Influenza nos Doentes com Patologia Cardiovascular com Menos de 65 Anos na Era COVID-19

Acta Médica Portuguesa, 2021
N/a.
Catarina Santos
doaj   +1 more source

Stalking influenza by vaccination with pre-fusion headless HA mini-stem. [PDF]

, 2016
Inaccuracies in prediction of circulating viral strain genotypes and the possibility of novel reassortants causing a pandemic outbreak necessitate the development of an anti-influenza vaccine with increased breadth of protection and potential for rapid ...
Carnell, George, Temperton, Nigel J., Mallajosyula, VVA, Poon, Leo LM, Mallajosyula, V Vamsee Aditya, Temperton, N, Poon, LLM, Chin, Alex WH, Mallajosyula, VV, Chin, Alex W H, Carnell, G, Valkenburg, Sophie A, Li, OTW, Poon, Leo L M, Chin, WH, Mallajosyula, Vamsee Aditya V, Poon, LML, Li, Olive T W, Varadarajan, Raghavan, Doak, SA, Li, Olive TW, Temperton, Nigel, Chin, AWH, Valkenburg, SA, Varadarajan, R   +24 more
core   +1 more source

Vacina contra o vírus da influenza e mortalidade por doenças cardiovasculares na cidade de São Paulo Vacuna contra el virus de la Influenza y mortalidad por enfermedades cardiovasculares en la Ciudad de São Paulo Vaccination against the influenza virus and mortality due to cardiovascular diseases in the city of Sao Paulo

Arquivos Brasileiros de Cardiologia, 2009
FUNDAMENTO: A influência da vacinação contra o vírus da gripe na mortalidade por doenças cardiovasculares (DCV) é controversa. OBJETIVO: Analisar a mortalidade por DCV antes e depois do início da vacinação contra a gripe na cidade de São Paulo.
Antonio de Padua Mansur, Desidério Favarato, José Antonio F. Ramires   +2 more
doaj   +1 more source

Hospital morbidity among elderly patients, before and after influenza vaccination in the state of Paraná Morbilidad hospitalaria, en ancianos, antes y después de la vacunación contra la influenza en el estado de Paraná Morbidade hospitalar em idosos antes e após vacinação contra influenza no estado do Paraná

Revista Latino-Americana de Enfermagem, 2008
This ecological study was developed to evaluate the patterns in hospital morbidity due respiratory diseases among people over 60 years old residing in the State of Paraná, before and after the implementation of vaccination campaigns against influenza ...
Ana Lúcia Mendes Ferrer, Sonia Silva Marcon, Rosangela Getirana Santana   +2 more
doaj   +1 more source

Fatores associados ao óbito dos casos graves de influenza A(H1N1)pdm09

Cadernos de Saúde Coletiva, 2018
Resumo Introdução A primeira pandemia de influenza do século XXI ocorreu em 2009, causada pelo novo subtipo de vírus da gripe, o vírus influenza A(H1N1)pdm09.
Gustavo Machado Felinto, Claudia Caminha Escosteguy, Roberto de Andrade Medronho   +2 more
doaj   +1 more source

Influenza vaccination: knowledge, attitudes and practices of the elderly

Revista de Enfermagem da Universidade Federal de Santa Maria, 2016
Aim: To investigate the knowledge, attitudes and practices of elderly patients about influenza and the vaccine used to prevent the disease. Methodology: Descriptive study with 71 seniors who were interviewed by way of a questionnaire based on KAP survey (
Adriana Delmondes de Oliveira, Annelita Almeida Oliveira Reiners, Priscila Aguiar Mendes, Rosemeiry Capriata Souza Azevedo, Ana Carolina Macri Gaspar   +4 more
doaj   +1 more source

Eventos adversos de la vacuna contra la Influenza Humana A H1N1 en Tumbes

Manglar, 2013
Problema: ¿Cuáles son los eventos adversos que produce la Vacuna contra la Influenza Humana AH1N1 en la población inmunizada en Tumbes el 2010? Objetivos: determinar la frecuencia, el tipo y la intensidad de los eventos adversos.
Nestor Purizaga Izquierdo
doaj   +1 more source